A recent study in melanoma suggests that this may be possible: RNA-LPX vaccine encoding MAGEA3, NY-ESO-1, tyrosinase and transmembrane phosphatase with tensin homology (TPTE) were tested in checkpoint-inhibitor (CPI)-treated patients with unresectable melanoma. The gene discussed is MAGEA3; the disease is melanoma.